Cattaneo, D.; Ridolfo, A.L.; Giacomelli, A.; Cossu, M.V.; Dolci, A.; Gori, A.; Antinori, S.; Gervasoni, C.
Impact of Glucagon-like Peptide 1 Receptor Agonists on Body Weight in People with HIV and Diabetes Treated with Integrase Inhibitors. Diabetology 2025, 6, 20.
https://doi.org/10.3390/diabetology6030020
AMA Style
Cattaneo D, Ridolfo AL, Giacomelli A, Cossu MV, Dolci A, Gori A, Antinori S, Gervasoni C.
Impact of Glucagon-like Peptide 1 Receptor Agonists on Body Weight in People with HIV and Diabetes Treated with Integrase Inhibitors. Diabetology. 2025; 6(3):20.
https://doi.org/10.3390/diabetology6030020
Chicago/Turabian Style
Cattaneo, Dario, Anna Lisa Ridolfo, Andrea Giacomelli, Maria Vittoria Cossu, Alberto Dolci, Andrea Gori, Spinello Antinori, and Cristina Gervasoni.
2025. "Impact of Glucagon-like Peptide 1 Receptor Agonists on Body Weight in People with HIV and Diabetes Treated with Integrase Inhibitors" Diabetology 6, no. 3: 20.
https://doi.org/10.3390/diabetology6030020
APA Style
Cattaneo, D., Ridolfo, A. L., Giacomelli, A., Cossu, M. V., Dolci, A., Gori, A., Antinori, S., & Gervasoni, C.
(2025). Impact of Glucagon-like Peptide 1 Receptor Agonists on Body Weight in People with HIV and Diabetes Treated with Integrase Inhibitors. Diabetology, 6(3), 20.
https://doi.org/10.3390/diabetology6030020